PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of General Pharmacology and Toxicology, University Hospital Frankfurt am Main, Goethe-University, Theodor-Stern Kai 7, 60590 Frankfurt am Main, Germany.\', \'KOSA Pharma GmbH, 60590 Frankfurt am Main, Germany.\', \'Institute of Medical Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 41910.3390/medicina58030419
?:hasPublicationType
?:journal
  • Medicina (Kaunas, Lithuania)
is ?:pmid of
?:pmid
?:pmid
  • 35334595
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.422
?:rankingScore_hIndex
  • 29
is ?:relation_isRelatedTo_publication of
?:title
  • Dyspnea in Post-COVID Syndrome following Mild Acute COVID-19 Infections: Potential Causes and Consequences for a Therapeutic Approach.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all